TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% w/v
COMPOSITION
Each ml contains: Tobramycin Sulphate USP equivalent to Tobramycin ....... 0.3% w/v, Benzalkonium Chloride Solution IP (as Preservative) ...... 0.02% v/v, Sterile Aqueous Base ..... q.s.,With HPMC
INTRODUCTION
Ophthalmic preparations with antibiotics and/or sulphonamides.
INDICATIONS
TOBRAEYE is a topical antibiotic indicated in the treatment of external bacterial infections of the eye and its adnexa caused by susceptible organisms. Appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of TOBRAEYE
DIRECTIONS
TOBRAEYE ophthalmic solution instil one or two drops into the affected eye(s) every four hours. In severe, infections instil two drops into the eye(s) every hour until
improvement following which treatment should be reduced prior to discontinuation.
WARNINGS
As the possibility of adverse effects on the corneal permeability and the danger of disruption of
the corneal epithelium with prolonged or repeated usage of benzalkonium chloride preserved preparations
cannot be excluded, regular ophthalmological examination is required. Caution should be exercised in the use
of benzalkonium chloride preserved topical medication over an extended period in patients with extensive
ocular surface disease.
SIDE EFFECTS
Localised ocular toxicity and hypersensitivity can occur. If topical ocular tobramycin is administered concomitantly with systemic aminoglycoside antibiotics, care should be taken to monitor the total serum concentration.
PACKING
TOBRAEYE is supplied in sterile dropper vial.
Storage :
Store in cool & dry place. Protect from light. Use the solution within one month after opening the container. For external use only.
Medicine :
Keep out of reach of children.
Use the solution within
one month after opening the container.
For external use only.